Vimarsana
Biggest News Aggregation in the World

Page 14 - Small Molecules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecules Today - Breaking & Trending Today

Global Conjugation & Labeling Services Market 2023-2035: Outsourcing Trend Propels Market Surge - Vimarsana News

Global Conjugation & Labeling Services Market 2023-2035: Outsourcing Trend Propels Market Surge

/PRNewswire/ -- The "Conjugation and Labeling Services Market: Distribution by Type of Molecule, Type of Molecular Conjugate / Label, and Key Geographical...

Are mushrooms an effective early dietary intervention for Alzheimer's Disease? - Vimarsana News

Are mushrooms an effective early dietary intervention for Alzheimer's Disease?

In a study published in the journal Foods, researchers reviewed available literature on the potential anti-Alzheimer's disease properties of mushrooms.

Nanotechnology's triple threat: Advancing precision cancer treatment - Vimarsana News

Nanotechnology's triple threat: Advancing precision cancer treatment

The design of tumor tissue-, cell-, and organelle-targeted cancer nanomedicines.

Short Interest in Lonza Group AG (OTCMKTS:LZAGY) Rises By 6.6% - Vimarsana News

Short Interest in Lonza Group AG (OTCMKTS:LZAGY) Rises By 6.6%

Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 6,500 shares, an increase of 6.6% from the June 15th total of 6,100 shares. Based on an average daily volume of 187,800 shares, the short-interest ratio […]

Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin - Vimarsana News

Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin

Lonza Group AG / Key word: Half Year Results Lonza Delivers 5.6% CER Sales Growth, With Underlying Growth at Around 10% CER and 30% CORE EBITDA Margin 21-Jul-2023 / 07:00...